2237-0185 Screening compound: 4-fluoro-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide

2237-0185 Screening compound: 4-fluoro-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide
2237-0185 Screening compound: 4-fluoro-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2237-0185
4-fluoro-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2237-0185

Molecular Formula

C15H10FN3OS (C15 H10 FN3 OS)

Compound Name

4-fluoro-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide

IUPAC name

4-fluoro-N-(5-phenyl-134-thiadiazol-2-yl)benzamide

SMILES

O=C(c(cc1)ccc1F)Nc1nnc(-c2ccccc2)s1

InChI

InChI=1S/C15H10FN3OS/c16-12-8-6-10(7-9-12)13(20)17-15-19-18-14(21-15)11-4-2-1-3-5-11/h1-9H,(H,17,19,20)

InChI Key

IYOKSZDPCVQRAS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00753989

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

299.33

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

3.755

Distribution Coefficient, logD

3.711

Water Solubility, LogSw

-4.25

Polar Surface Area

46.603

Acid Dissociation Constant (pKa)

8.37

Base Dissociation Constant (pKb)

-3.52

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

2237-0185 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Annotated Library (21441 compounds)

Human Receptors Annotated Library (5376 compounds)

Human Transcription Factors Annotated Library (5098 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 2237-0185 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2237-0185?
Check Price and Availability of 2237-0185, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2237-0185 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2237-0185
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2237-0185
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2237-0185 available by request